Global & Public Health (all articles)
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
11 Apr, 2022 | 01:40h | UTC
Clinical care of severe acute respiratory infections – Tool kit (COVID-19 adaptation, update 2022).
11 Apr, 2022 | 01:45h | UTCClinical care of severe acute respiratory infections – Tool kit – World Health Organization
Commentary on Twitter (thread – click for more)
Updated toolkit for the clinical care of severe acute respiratory infections including:
🔸 severe #pneumonia
🔸 acute respiratory distress syndrome
🔸 sepsis & septic shock👉 https://t.co/ROvKZz12LT pic.twitter.com/LdcNJiJcxA
— World Health Organization (WHO) (@WHO) April 8, 2022
Perspective: Supervised consumption sites—a tool for reducing risk of overdose deaths and infectious diseases in people who use illicit drugs.
11 Apr, 2022 | 00:59h | UTCSupervised Consumption Sites—A Tool for Reducing Risk of Overdose Deaths and Infectious Diseases in People Who Use Illicit Drugs – JAMA (free for a limited period)
Commentary on Twitter
NYC last fall opened the first 2 US supervised consumption sites, where people can use illicit drugs under the watchful eye of staff trained to reverse overdoses, but such centers have operated elsewhere—sometimes under the radar—for decades. https://t.co/mS7wLZd164
— JAMA (@JAMA_current) April 6, 2022
Opinion | Why the WHO took two years to say COVID is airborne.
8 Apr, 2022 | 10:38h | UTCWhy the WHO took two years to say COVID is airborne – Nature
Putting positive experiences at the center of postnatal care.
8 Apr, 2022 | 10:34h | UTCPutting positive experiences at the centre of postnatal care – Evidently Cochrane Blog
Original Guideline: WHO recommendations on maternal and newborn care for a positive postnatal experience.
Systematic Review: How the reduction of working hours could influence health outcomes.
8 Apr, 2022 | 09:50h | UTC
Systematic Review: Approaches and outcomes of community health worker’s interventions for hypertension management and control in low-income and middle-income countries.
8 Apr, 2022 | 09:48h | UTC
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines.
7 Apr, 2022 | 10:00h | UTCRelated:
Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Commentary on Twitter (thread – click for more)
#JustPublished!#ECDC and @EMA_News issue advice on fourth doses of mRNA #COVID19 vaccines.
Read the full joint statement: https://t.co/hBuOlrfKOD pic.twitter.com/aO5vSyYvTk
— ECDC (@ECDC_EU) April 6, 2022
Perspective | An equitable roadmap for ending the COVID-19 pandemic.
7 Apr, 2022 | 08:48h | UTCAn equitable roadmap for ending the COVID-19 pandemic – Nature Medicine
Commentary on Twitter
A Comment article in @NatureMedicine argues that the COVID-19 pandemic will end only with a renewed focus on equitable distribution of vaccines and therapeutics, responsive public health plans, and policies to protect the vulnerable. https://t.co/2cZShdqnY3
— Nature Portfolio (@NaturePortfolio) April 6, 2022
WHO Strategic framework for collaboration on antimicrobial resistance.
7 Apr, 2022 | 08:41h | UTCStrategic framework for collaboration on antimicrobial resistance – World Health Organization
Related:
Four priority actions to slow the silent pandemic of antimicrobial resistance.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Commentary on Twitter
#DYK: Drug resistant organisms are found in people, animals, food, plants and the environment.
That's why WHO works in collaboration with @FAO, @OIEAnimalHealth & @UNEP to address #AntimicrobialResistance https://t.co/enhUb1jg2g pic.twitter.com/9elCBspx4y— World Health Organization (WHO) (@WHO) April 6, 2022
Observational study suggests a fourth dose of the Pfizer vaccine provided additional protection against severe disease in patients 60 years of age or older during the Omicron wave in Israel.
6 Apr, 2022 | 10:59h | UTCProtection by a Fourth Dose of BNT162b2 against Omicron in Israel – New England Journal of Medicine
Commentary: Mixed Bag for Fourth Dose of Pfizer Vaccine vs Omicron— Real-world data show less infection and severity, but long-term benefit less clear – MedPage Today (free registration required)
Related:
Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Commentary on Twitter
Just published @NEJM
4th dose vaccine protection in >620,000 people vs 3-doses in >620,000, all age 60+, Omicron wave, Israel
—4-fold lower rate of severe disease, no waning at 6 weeks
—2-fold lower rate of infection, rapidly wanedhttps://t.co/g8uGMXGHD6 pic.twitter.com/D7WHywTI1j— Eric Topol (@EricTopol) April 5, 2022
Retrospective cohort study: Waning COVID-19 vaccine effectiveness for Pfizer and CoronaVac in Malaysia.
6 Apr, 2022 | 10:57h | UTC
Commentary on Twitter
@ICR_NIH RECoVam's
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia in IJID.https://t.co/QwNSRQBKOq• Against infections, both wane after 3-5 months
• Against ICU admission, CoronaVac wane
• Against death, both retain considerable effectiveness— Dr Kalai Peariasamy (@drkalai61) March 22, 2022
Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019.
6 Apr, 2022 | 10:49h | UTCNews Release: Global disparities persist in opioid painkiller access – University College London
Invited Commentary: Closing the global pain divide: balancing access and excess – The Lancet Public Health
Commentary on Twitter (article and images under a Creative Commons Attribution (CC BY 4.0 license)
Just Out @TheLancetPH 🚨
Global #opioids consumption increased from 2015 to 2019‼️#Disparities in opioid💊consumption remained, indicating potential inadequate access to essential pain relief in countries with low consumption🌐https://t.co/bkcdgLy3ZP pic.twitter.com/RUGl1gbiTw— Gil Morgan, MD (@weoncologists) April 1, 2022
Billions of people still breathe unhealthy air: new WHO data.
5 Apr, 2022 | 09:59h | UTCNews Release: Billions of people still breathe unhealthy air: new WHO data – World Health Organization
Report: WHO Air quality Database 2022
Commentaries:
WHO says 99% of world’s population breathes poor-quality air – Associated Press
Related: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.
Commentary on Twitter (thread – click for more)
Shocking!
99% – or almost the entire world's population breathes air with unhealthy levels of fine particulate matter & nitrogen dioxide, and threatens their health.
More: https://t.co/Llaj2wHk0V #HealthierTomorrow pic.twitter.com/QlHUP4iyS4— World Health Organization (WHO) (@WHO) April 4, 2022
Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.
5 Apr, 2022 | 09:46h | UTCRelated:
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Commentary on Twitter
https://twitter.com/hildabast/status/1509724907965665280
Cohort Study: Change in heart disease and stroke mortality before and during the Covid-19 pandemic.
5 Apr, 2022 | 08:47h | UTCCommentaries:
Several-Fold Increase in Stroke and Heart Disease Deaths During COVID-19 Pandemic – NeurologyToday
2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up – HealthDay
Commentary from the author on Twitter (thread – click for more). Article and images under CC-BY License
Our paper @JAMANetworkOpen Sidney et al. https://t.co/bfCX9akd6p 2019 – 2020, several-fold ⬆️ in risk-associated deaths from Heart Disease & Stroke, with greater ⬆️ minorities & highest ⬆️among Black adults. More evidence of underlying systemic inequities & structural racism 🧵 pic.twitter.com/goQgPmRU9c
— Jamal Rana, MD (@JamalRanaMD) March 23, 2022
WHO Strategic preparedness, readiness and response plan to end the global Covid-19 emergency in 2022.
4 Apr, 2022 | 01:44h | UTC
Commentary on Twitter (thread – click for more)
"WHO is releasing updated Strategic Preparedness, Readiness & Response Plan for #COVID19. This is our 3rd strategic plan for COVID-19, & it could & should be our last. It lays out 3️⃣ possible scenarios for how the pandemic could evolve this year"-@DrTedros https://t.co/ryb0QdlTqG
— World Health Organization (WHO) (@WHO) March 30, 2022
RCT: Higher dose primaquine more effective for preventing relapse of Plasmodium vivax Malaria compared to standard dose.
4 Apr, 2022 | 01:25h | UTC
Commentaries on Twitter
To prevent relapse of Plasmodium vivax malaria, primaquine at a total dose of 7.0 mg per kilogram had higher efficacy than a total dose of 3.5 mg per kilogram. https://t.co/qIu27ruhKP pic.twitter.com/HdTNhqB0J1
— NEJM (@NEJM) April 1, 2022
In most of the Americas, recommended primaquine-based therapy for P. vivax malaria has moderate efficacy for preventing relapse. Whether higher-dose primaquine might reduce recurrence is unknown. New research findings are summarized in a short video. https://t.co/aFt9gNGg0m pic.twitter.com/oiAkLMgPIJ
— NEJM (@NEJM) April 2, 2022
Two new studies show vaccination provides additional protection after Covid-19 infection.
4 Apr, 2022 | 01:16h | UTCCommentaries:
Vaccines offer substantial extra protection after COVID-19 infection – CIDRAP
Had COVID? Getting Vaccine Boosts Resilience Even More, Studies Show – HealthDay
Related:
Commentary on Twitter (thread – click for more)
THREAD | New studies in @TheLancetInfDis confirm #COVID19 vaccines provide extra protection for those with immunity from previous infection, especially against severe disease ⤵️
(Cases of reinfection from omicron variants not included)
— The Lancet (@TheLancet) April 1, 2022
WHO launches global initiative to tackle deadly insect-borne ‘arboviruses’.
4 Apr, 2022 | 00:57h | UTCWHO launches Global Initiative to Tackle Deadly Insect-Borne ‘Arboviruses’ – Health Policy Watch
WHO’s training for caregivers of children with autism goes online.
4 Apr, 2022 | 00:59h | UTCNews Release: WHO’s training for caregivers of children with autism goes online – World Health Organization
Online Course: WHO eLearning Caregiver Skills Training for Families of Children with Developmental Delays or Disabilities – OpenWHO
Systematic Review: Does giving money to people, in low- and middle-income countries, without conditions attached lead to better health and other life improvements?
1 Apr, 2022 | 10:05h | UTC
No flight, no bite: ‘Mosquito grounding’ bed net nearly halves malaria infection in Tanzanian children.
1 Apr, 2022 | 08:41h | UTCInvited Commentary: A new generation of long-lasting insecticidal nets – The Lancet (free registration required)
Commentary on Twitter
Mosquitoes developing resistance to the insecticides used in bed nets became a large problem in the fight against malaria.
This study finds that nets treated with a new insecticide cut malaria rates in children *by almost half* compared to the usual ones.https://t.co/rRoyFzIhWf
— Max Roser (@MaxCRoser) March 28, 2022
WHO Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022–2032.
31 Mar, 2022 | 08:45h | UTCNews Release: WHO releases 10-year strategy for genomic surveillance of pathogens – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 Today @WHO published the Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential (2022–2032)
Ambitious, comprehensive, strategic and necessary.
Short thread ⬇️https://t.co/98NMgMhbL6
— Maria Van Kerkhove (@mvankerkhove) March 30, 2022
WHO recommendations on maternal and newborn care for a positive postnatal experience.
31 Mar, 2022 | 08:47h | UTCNews Release: WHO urges quality care for women and newborns in critical first weeks after childbirth – World Health Organization
Commentary: Postnatal care: WHO highlights urgency of physical and mental support – The BMJ